NCT03877315

Brief Summary

Stemless shoulder arthroplasty systems with uncemented metaphyseal fixation have been used in Europe for glenohumeral osteoarthritis since 2004. The stemless design has several theoretical advantages compared with the stemmed shoulder arthroplasty systems: restoring patients' anatomy, preserving humeral bone stock, and few complications in component removal if the need for a revision arthroplasty arises. The purpose of the study is to compare the short-term, patient-reported outcome of stemless and stemmed total shoulder arthroplasty.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

December 22, 2022

Status Verified

December 1, 2022

Enrollment Period

2.6 years

First QC Date

March 12, 2019

Last Update Submit

December 21, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Western Ontario Osteoarthritis of the Shoulder Score (WOOS)

    The WOOS is a patient-administered, disease-specific ques¬tionnaire for measurement of the quality of life of patients with osteoarthritis. It provides scores for four domains: (1) physical symptoms; (2) sport, recreation, and work; (3) lifestyle; and (4) emotions. Patients answer each question using the visual analogue scale. The WOOS score is calculated by measuring the distance from the left side of the line and calculating the possible score ranging from 0 to 100 (recorded to the nearest 0.5 mm.) It consists of 19 questions, and the total score ranges from 0 to 1900. A maximum score of 1900 signifies that the patient has an extreme decrease in shoulder-related quality of life, whereas a score of 0 signifies that the patient has no decrease in shoulder-related quality of life. The questionnaire has been translated into Danish and validated and tested on patients with shoulder osteoarthritis.

    12 months after surgery

Secondary Outcomes (3)

  • Western Ontario Osteoarthritis of the Shoulder Score (WOOS)

    3 months after surgery

  • Oxford Shoulder Score (OSS)

    3 and 12 months after surgery

  • EQ-5D questionnaire

    3 and 12 months after surgery

Study Arms (2)

Stemmed

ACTIVE COMPARATOR

Subjects operated with stemmed shoulder arthroplasty, Biomet Comprehensive® Total Shoulder System.

Device: Stemmed shoulder arthroplasty, Biomet Comprehensive® Total Shoulder System.

Non-Stemmed

ACTIVE COMPARATOR

Subjects operated with stemless shoulder arthroplasty, Biomet Comprehensive® Nano Shoulder System.

Device: Stemless shoulder arthroplasty, Biomet Comprehensive® Nano Shoulder System.

Interventions

A total shoulder prosthesis used in treating glenohumeral osteoarthritis

Stemmed

A total shoulder prosthesis used in treating glenohumeral osteoarthritis

Non-Stemmed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged ≥ 18 years.
  • Patients have been referred to the Orthopedic Department or Zealand University Hospital, Koege or Hvidovre University Hospital for shoulder pain during the study period.
  • Patients have the ability to read trial information in Danish and give informed consent.
  • The diagnosis will be based on plain radiographs (at least two perpendicular views), reduction of joint space, and/or osteophyte formation.
  • Clinical presentation with pain at night and/or daily pain, pain in overhead activity, and consumption of pain medication.

You may not qualify if:

  • Previous shoulder surgery that involves the humeral head and/or the glenoid cavity.
  • Patients with alcohol or drug abuse problems that can compromise rehabilitation and follow-up appointments as assessed by the recruiting surgeon at the first visit.
  • Patients unable to understand instructions in Danish, follow the rehabilitation protocol, or answer the questionnaires because of physical or cognitive inabilities as evaluated by the recruiting surgeon at the first visit.
  • Brachial plexus palsy.
  • Patients with previous fractures around the shoulder (clavicle, scapula, and proximal humerus fractures).
  • Patients with MRI scan-verified full thickness total tear of one or more of the rotator cuff tendons.
  • Patients with CT scan-verified glenoid retroversion ≥ 20° that does not allow glenoid component fixation without bone graft or need an augmented glenoid component.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zealand University Hospital

Køge, 4600, Denmark

Location

Related Publications (1)

  • Issa Z, Rasmussen JV, Petersen JK, Schantz K, Brorson S. Patient-reported outcome after stemmed versus stemless total shoulder arthroplasty for glenohumeral osteoarthritis: a patient-blinded randomized clinical trial. Trials. 2019 Jul 12;20(1):427. doi: 10.1186/s13063-019-3535-9.

MeSH Terms

Conditions

Shoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Zaid Issa, MD

    Zealand University Hospital Koege

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will be blinded to which implant type they are receive. This will be done by not sharing the operation chart files with the patient's online file records; the inserted shoulder prosthesis will be noted by a unique code in operation file, and the radiologist will be asked not to describe the post-operation x-ray controls. The primary investigator will conduct the blinded statistical analysis supervised by the biostatistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor, shoulder and elbow surgeon.

Study Record Dates

First Submitted

March 12, 2019

First Posted

March 15, 2019

Study Start

August 1, 2019

Primary Completion

February 28, 2022

Study Completion

August 1, 2023

Last Updated

December 22, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations